Home
About Us
Covid-19
NRX-100/101
News
Contact
Home
News
Broadcasts
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial
Broadcasts
Related Posts
Press releases
NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint
Read more
News
Which COVID-19 treatments are showing promise? A list of potential drugs
Read more
Press releases
NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19
Read more
